Skip to main content
AstraZeneca Pharma India Limited (BOM: 506820)
India flag India · Delayed Price · Currency is INR
6,949.85
+35.90 (0.52%)
At close: Jan 20, 2025

AstraZeneca Pharma India Revenue

AstraZeneca Pharma India had revenue of 4.08B INR in the quarter ending September 30, 2024, with 31.16% growth. This brings the company's revenue in the last twelve months to 14.85B, up 30.10% year-over-year. In the fiscal year ending March 31, 2024, AstraZeneca Pharma India had annual revenue of 12.96B with 29.17% growth.

Revenue (ttm)
14.85B
Revenue Growth
+30.10%
P/S Ratio
11.70
Revenue / Employee
18.56M
Employees
940
Market Cap
173.75B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202412.96B2.93B29.17%
Mar 31, 202310.03B1.97B24.50%
Mar 31, 20228.06B-79.60M-0.98%
Mar 31, 20218.14B-182.50M-2.19%
Mar 31, 20208.32B1.04B14.21%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,398.38B
Tata Consultancy Services 2,520.82B
HDFC Bank 2,761.06B
Bharti Airtel 1,554.78B
ICICI Bank 1,638.51B
Infosys 1,635.60B
State Bank of India 3,360.28B
ITC Limited 751.35B
Revenue Rankings

AstraZeneca Pharma India News

More News